{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,20]],"date-time":"2026-05-20T21:01:38Z","timestamp":1779310898884,"version":"3.51.4"},"reference-count":51,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Fondo de Ciencia, Tecnolog\u00eda e Innovaci\u00f3n, Colombia"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:p>Diabetes mellitus is characterized by persistent hyperglycemia that triggers micro-vascular complications in organs such as the eyes and kidneys; a pivotal enzymatic driver is aldose reductase (AR), which reduces glucose to sorbitol. Because existing AR inhibitors often cause off-target toxicity, we implemented an integrative in-silico workflow to discover selective, safer compounds. A library of 4 975 small molecules was docked against AR and, in parallel, against five clinically relevant antitarget proteins or proteins whose unintended inhibition is associated with adverse pharmacological or toxicological effects (CYP2A6, CYP2C9, CYP3A4, SULT1A3 and the pregnane X receptor), retaining 236 ligands whose binding energies to every antitarget were weaker than those of the reference drug tolrestat. These survivors were redocked to five high-resolution human AR crystal structures, and the ten best-scoring ligands underwent 100 ns molecular-dynamics simulations followed by MM-PBSA free-energy calculations to refine affinity estimates and probe complex stability. Ligand 4934, a benzo[a]anthracene\u2013pyrene polyphenol, displayed the strongest predicted affinity for while showing poor affinity for the antitarget panel, outperforming tolrestat by more than 2\u00a0kcal mol\u207b\u00b9 and adopting a stable plug-like pose that occludes the catalytic pocket through extensive \u03c0\u2013\u03c0 and hydrophobic contacts with Trp111, Phe123 and Lys22. These findings highlight ligand 4934 as a promising scaffold for selective AR inhibition and demonstrate the effectiveness of the stepwise computational strategy in prioritizing lead compounds with reduced off-target liabilities.<\/jats:p>","DOI":"10.1038\/s41598-025-12859-x","type":"journal-article","created":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T11:19:11Z","timestamp":1754047151000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Computational screening identifies selective aldose reductase inhibitors with strong efficacy and limited off target interactions"],"prefix":"10.1038","volume":"15","author":[{"given":"Jicli Jose","family":"Rojas","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Roberto","family":"Pestana-Nobles","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Leonardo C.","family":"Pacheco-Londono","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jes\u00fas","family":"Utria-Munive","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nataly J.","family":"Galan-Freyle","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,8,1]]},"reference":[{"key":"12859_CR1","first-page":"1","volume":"42","author":"Standards of medical care in diabetes-2019","year":"2018","unstructured":"Standards of medical care in diabetes-2019. Am. Diabetes Association 42, 1\u201336 (2018).","journal-title":"Am. Diabetes Association"},{"key":"12859_CR2","unstructured":"Webber, S. International Diabetes Federation. Diabetes Research and Clinical Practice. Vol. 102 (2013)."},{"key":"12859_CR3","unstructured":"Global Burden of Disease Collaborative Network. Global Burden of Disease Study 2019. Results. Institute for Health Metrics and Evaluation (2020). https:\/\/vizhub.healthdata.org\/gbd-results\/"},{"key":"12859_CR4","doi-asserted-by":"publisher","first-page":"106326","DOI":"10.1016\/j.phrs.2022.106326","volume":"182","author":"S Sourbh","year":"2022","unstructured":"Sourbh, S. & Garg, J. G. Polyol pathway and redox balance in diabetes. Pharmacol. Res. 182, 106326 (2022).","journal-title":"Pharmacol. Res."},{"key":"12859_CR5","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1016\/j.plefa.2017.10.004","volume":"127","author":"DL Sheela","year":"2017","unstructured":"Sheela, D. L. et al. Coconut phytocompounds inhibits polyol pathway enzymes: implication in prevention of microvascular diabetic complications. Prostaglandins Leukot. Essent. Fat. Acids. 127, 20\u201324 (2017).","journal-title":"Prostaglandins Leukot. Essent. Fat. Acids"},{"key":"12859_CR6","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1016\/S0006-291X(02)02584-6","volume":"299","author":"S Amano","year":"2002","unstructured":"Amano, S. et al. Sorbitol dehydrogenase overexpression potentiates glucose toxicity to cultured retinal pericytes. Biochem. Biophys. Res. Commun. 299, 183\u2013188 (2002).","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"12859_CR7","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3390\/metabo11100655","volume":"11","author":"M Singh","year":"2021","unstructured":"Singh, M., Kapoor, A. & Bhatnagar, A. Physiological and pathological roles of aldose reductase. Metabolites 11, 1\u201329 (2021).","journal-title":"Metabolites"},{"key":"12859_CR8","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1016\/S1353-8020(02)00018-4","volume":"8","author":"C Mytilineou","year":"2002","unstructured":"Mytilineou, C., Kramer, B. C. & Yabut, J. A. Glutathione depletion and oxidative stress. Parkinsonism Relat. Disord. 8, 385\u2013387 (2002).","journal-title":"Parkinsonism Relat. Disord"},{"key":"12859_CR9","doi-asserted-by":"publisher","first-page":"2011","DOI":"10.1021\/bi00174a006","volume":"33","author":"DH Harrison","year":"1994","unstructured":"Harrison, D. H., Bohren, K. M., Ringed, D., Petsko, G. A. & Gabbay, K. H. An anion binding site in human aldose reductase: mechanistic implications for the binding of citrate, cacodylate, and glucose 6-Phosphate. Biochemistry 33, 2011\u20132020 (1994).","journal-title":"Biochemistry"},{"key":"12859_CR10","doi-asserted-by":"publisher","first-page":"601","DOI":"10.1016\/S0969-2126(97)00216-5","volume":"5","author":"A Urzhumtsev","year":"1997","unstructured":"Urzhumtsev, A. et al. A specificity pocket inferred from the Crystl structures of complexes of ar with the pharaeutically important ihiitors Tolrestat and sorbinil.pdf. Structure 5, 601\u2013612 (1997).","journal-title":"Structure"},{"key":"12859_CR11","first-page":"1","volume":"12","author":"F Balestri","year":"2022","unstructured":"Balestri, F., Moschini, R., Mura, U., Cappiello, M. & Del Corso, A. Search. Differ. Inhibitors Aldose Reductase Biomolecules 12, 1\u201312 (2022).","journal-title":"Search. Differ. Inhibitors Aldose Reductase Biomolecules"},{"key":"12859_CR12","unstructured":"Podjarny, A., Howard, E. & Sanishvili, R. Perspective on the structural basis for human aldo-keto reductase inhibition: Carboxylic acid versus cyclic imide inhibitors. Biomolecules. (2021)."},{"key":"12859_CR13","unstructured":"Miyamoto, T. Structural insights into aldose reductase inhibitors: Effects of pKa on cellular uptake (Doctoral Dissertation, University of Marburg) (2003)."},{"key":"12859_CR14","doi-asserted-by":"publisher","first-page":"1091","DOI":"10.2174\/1389200221666201016124125","volume":"21","author":"AS Grewal","year":"2020","unstructured":"Grewal, A. S., Thapa, K., Kanojia, N., Sharma, N. & Singh, S. Natural compounds as source of aldose reductase (AR) inhibitors for the treatment of diabetic complications: A mini review. Curr. Drug Metab. 21, 1091\u20131116 (2020).","journal-title":"Curr. Drug Metab."},{"key":"12859_CR15","doi-asserted-by":"crossref","unstructured":"Hollis Showalter, H. D. M. W. N-[[5-(Trifluoromethyl)-6-methoxy-1-naphthalenyl]thioxomethyl]-N-methylglycine (Tolrestat). J. Med. Chem. 27, 255\u2013256 (1984).","DOI":"10.1021\/jm00369a003"},{"key":"12859_CR16","first-page":"14","volume":"18","author":"AF Macleod","year":"1992","unstructured":"Macleod, A. F. et al. A multicentre trial of the aldose-reductase inhibitor tolrestat, in patients with symptomatic diabetic peripheral neuropathy. Diabete Metab. 18, 14\u201320 (1992).","journal-title":"Diabete Metab."},{"key":"12859_CR17","doi-asserted-by":"crossref","unstructured":"Steuber, H. et al. Expect the unexpected or caveat for drug designers: multiple structure determinations using aldose reductase crystals treated under varying soaking and Co-crystallisation conditions. J Mol. Biol 363, 174\u2013187 (2006).","DOI":"10.1016\/j.jmb.2006.08.011"},{"key":"12859_CR18","doi-asserted-by":"crossref","unstructured":"Julius, A. et al. Inhibition of aldose reductase by novel phytocompounds: A heuristic approach to treating diabetic retinopathy. Evid.-Based Complem. Altern. Med.  (2022).","DOI":"10.1155\/2022\/9624118"},{"key":"12859_CR19","doi-asserted-by":"publisher","first-page":"2595","DOI":"10.1021\/ci200203h","volume":"51","author":"AT Garc\u00eda-Sosa","year":"2011","unstructured":"Garc\u00eda-Sosa, A. T., Sild, S., Takkis, K. & Maran, U. Combined approach using ligand efficiency, cross-docking, and antitarget hits for wild-type and drug-resistant Y181C HIV-1 reverse transcriptase. J. Chem. Inf. Model. 51, 2595\u20132611 (2011).","journal-title":"J. Chem. Inf. Model."},{"key":"12859_CR20","doi-asserted-by":"crossref","unstructured":"Bowes, J. et al. Reducing safety-related drug attrition: the use of in vitro pharmacological profiling. Nat. Rev. Drug Discov. 11(12), 909\u2013922 (2012).","DOI":"10.1038\/nrd3845"},{"issue":"1","key":"12859_CR21","doi-asserted-by":"publisher","first-page":"336","DOI":"10.1124\/jpet.105.093229","volume":"316","author":"RS Obach","year":"2006","unstructured":"Obach, R. S. et al. The utility of in vitro cytochrome P450 Inhibition data in the prediction of drug\u2013drug interactions. J. Pharmacol. Exp. Ther. 316 (1), 336\u2013348 (2006).","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"12859_CR22","doi-asserted-by":"publisher","first-page":"19066","DOI":"10.1038\/s41598-023-46100-4","volume":"13","author":"R Patel","year":"2023","unstructured":"Patel, R. et al. Probing the effects of streptomycin on brassica Napus germination and assessing its molecular interactions using extensive molecular dynamics (MD) simulations. Sci. Rep. 13, 19066 (2023).","journal-title":"Sci. Rep."},{"key":"12859_CR23","doi-asserted-by":"publisher","first-page":"7975","DOI":"10.1038\/s41598-024-58584-9","volume":"14","author":"M Wang","year":"2024","unstructured":"Wang, M. & Liu, K. Molecular dynamics simulations to explore the binding mode between the amyloid-\u03b2 protein precursor (APP) and adaptor protein Mint2. Sci. Rep. 14, 7975 (2024).","journal-title":"Sci. Rep."},{"key":"12859_CR24","doi-asserted-by":"publisher","first-page":"1630","DOI":"10.3390\/ijms23031630","volume":"23","author":"R Pestana-Nobles","year":"2022","unstructured":"Pestana-Nobles, R. et al. Docking and molecular dynamic of microalgae compounds as potential inhibitors of Beta-Lactamase. Int. J. Mol. Sci. 23, 1630 (2022).","journal-title":"Int. J. Mol. Sci."},{"key":"12859_CR25","doi-asserted-by":"publisher","first-page":"8620","DOI":"10.1038\/s41598-024-59292-0","volume":"14","author":"KM de Santiago-Silva","year":"2024","unstructured":"de Santiago-Silva, K. M., Camargo, P. G. & Constant, C. Molecular modelling studies and in vitro enzymatic assays identified A 4-(nitrobenzyl)guanidine derivative as inhibitor of SARS-CoV-2 Mpro. Sci. Rep. 14, 8620 (2024).","journal-title":"Sci. Rep."},{"key":"12859_CR26","doi-asserted-by":"publisher","first-page":"8457","DOI":"10.1038\/s41598-024-59063-x","volume":"14","author":"P Kamboj","year":"2024","unstructured":"Kamboj, P. et al. Design, synthesis, biological assessment and molecular modeling studies of novel imidazothiazole-thiazolidinone hybrids as potential anticancer and anti-inflammatory agents. Sci. Rep. 14, 8457 (2024).","journal-title":"Sci. Rep."},{"key":"12859_CR27","doi-asserted-by":"publisher","first-page":"2146","DOI":"10.1038\/s41598-023-28226-7","volume":"13","author":"MAA Ibrahim","year":"2023","unstructured":"Ibrahim, M. A. A. et al. In Silico drug discovery of SIRT2 inhibitors from natural source as anticancer agents. Sci. Rep. 13, 2146 (2023).","journal-title":"Sci. Rep."},{"key":"12859_CR28","doi-asserted-by":"publisher","first-page":"822","DOI":"10.1038\/nsmb971","volume":"12","author":"JK Yano","year":"2005","unstructured":"Yano, J. K., Hsu, M. H., Griffin, K. J., Stout, C. D. & Johnson, E. F. Structures of human microsomal cytochrome P450 2A6 complexed with coumarin and Methoxsalen. Nat. Struct. Mol. Biol. 12, 822\u2013823 (2005).","journal-title":"Nat. Struct. Mol. Biol."},{"key":"12859_CR29","doi-asserted-by":"publisher","first-page":"6987","DOI":"10.1021\/jm060519r","volume":"49","author":"JK Yano","year":"2006","unstructured":"Yano, J. K. et al. Synthetic inhibitors of cytochrome P-450 2A6: inhibitory activity, difference spectra, mechanism of inhibition, and protein cocrystallization. J. Med. Chem. 49, 6987\u20137001 (2006).","journal-title":"J. Med. Chem."},{"key":"12859_CR30","doi-asserted-by":"publisher","first-page":"35630","DOI":"10.1074\/jbc.M405427200","volume":"279","author":"MR Wester","year":"2004","unstructured":"Wester, M. R. et al. The structure of human cytochrome P450 2C9 complexed with flurbiprofen at 2.0-\u00c5 resolution. J. Biol. Chem. 279, 35630\u201335637 (2004).","journal-title":"J. Biol. Chem."},{"key":"12859_CR31","doi-asserted-by":"publisher","first-page":"5476","DOI":"10.1021\/acs.biochem.7b00795","volume":"56","author":"K Maekawa","year":"2017","unstructured":"Maekawa, K. et al. Structural basis of Single-Nucleotide polymorphisms in cytochrome P450 2C9. Biochemistry 56, 5476\u20135480 (2017).","journal-title":"Biochemistry"},{"key":"12859_CR32","doi-asserted-by":"publisher","first-page":"13011","DOI":"10.1002\/anie.201707324","volume":"56","author":"R Liu","year":"2017","unstructured":"Liu, R. et al. Determinants of the Inhibition of DprE1 and CYP2C9 by antitubercular thiophenes. Angewandte Chemie - Int. Ed. 56, 13011\u201313015 (2017).","journal-title":"Angewandte Chemie - Int. Ed."},{"key":"12859_CR33","unstructured":"Ekroos, M. & Sjo, T. Ekroos-2006-Structural Basis for .pdf (2006)."},{"key":"12859_CR34","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1016\/j.bbrc.2005.07.091","volume":"335","author":"JH Lu","year":"2005","unstructured":"Lu, J. H. et al. Crystal structure of human sulfotransferase SULT1A3 in complex with dopamine and 3\u2032-phosphoadenosine 5\u2032-phosphate. Biochem. Biophys. Res. Commun. 335, 417\u2013423 (2005).","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"12859_CR35","doi-asserted-by":"publisher","first-page":"1430","DOI":"10.1021\/bi0268753","volume":"42","author":"RE Watkins","year":"2003","unstructured":"Watkins, R. E. et al. 2.1 \u00c5 crystal structure of human PXR in complex with the st. John\u2019s wort compound Hyperforin. Biochemistry 42, 1430\u20131438 (2003).","journal-title":"Biochemistry"},{"key":"12859_CR36","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1186\/s13321-021-00548-6","volume":"13","author":"C Bouysset","year":"2021","unstructured":"Bouysset, C. & Fiorucci, S. ProLIF: a library to encode molecular interactions as fingerprints. J. Cheminform. 13, 72. https:\/\/doi.org\/10.1186\/s13321-021-00548-6 (2021).","journal-title":"J. Cheminform"},{"key":"12859_CR37","doi-asserted-by":"publisher","unstructured":"Berman, H. M. et al. The protein data bank (2000). Nucleic Acids Res. 28 (235-242). https:\/\/doi.org\/10.1093\/nar\/28.1.235 (2000). https:\/\/www.rcsb.org\/","DOI":"10.1093\/nar\/28.1.235"},{"key":"12859_CR38","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1046\/j.1463-1326.2002.00182.x","volume":"4","author":"\u00d6 Azal","year":"2002","unstructured":"Azal, \u00d6. et al. Effects of aminoguanidine and Tolrestat on the development of ocular and renal structural changes in experimental diabetic rats. Diabetes Obes. Metab. 4, 75\u201379 (2002).","journal-title":"Diabetes Obes. Metab."},{"key":"12859_CR39","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1016\/j.ejmech.2018.04.015","volume":"152","author":"I Crespo","year":"2018","unstructured":"Crespo, I. et al. Design, synthesis, structure-activity relationships and X-ray structural studies of novel 1-oxopyrimido[4,5-c]quinoline-2-acetic acid derivatives as selective and potent inhibitors of human aldose reductase. Eur. J. Med. Chem. 152, 160\u2013174 (2018).","journal-title":"Eur. J. Med. Chem."},{"key":"12859_CR40","doi-asserted-by":"publisher","first-page":"3681","DOI":"10.1016\/j.febslet.2013.09.031","volume":"587","author":"L Zhang","year":"2013","unstructured":"Zhang, L. et al. Inhibitor selectivity between aldo-keto reductase superfamily members AKR1B10 and AKR1B1: role of Trp112 (Trp111). FEBS Lett. 587, 3681\u20133686 (2013).","journal-title":"FEBS Lett."},{"key":"12859_CR41","doi-asserted-by":"publisher","first-page":"D1373","DOI":"10.1093\/nar\/gkac956","volume":"51","author":"S Kim","year":"2023","unstructured":"Kim, S. et al. PubChem 2023 update. Nucleic Acids Res. 51, D1373\u2013D1380. https:\/\/doi.org\/10.1093\/nar\/gkac956 (2023). https:\/\/pubchem.ncbi.nlm.nih.gov\/","journal-title":"Nucleic Acids Res."},{"key":"12859_CR42","doi-asserted-by":"publisher","first-page":"3891","DOI":"10.1021\/acs.jcim.1c00203","volume":"61","author":"J Eberhardt","year":"2021","unstructured":"Eberhardt, J., Santos-Martins, D., Tillack, A. F. & Forli, S. AutoDock Vina 1.2.0: new Docking methods, expanded force field, and python bindings. J. Chem. Inf. Model. 61, 3891\u20133898 (2021).","journal-title":"J. Chem. Inf. Model."},{"key":"12859_CR43","unstructured":"Case, D. A. et al.  Preprint  (2022)."},{"key":"12859_CR44","doi-asserted-by":"crossref","unstructured":"Simmerling, C. T. et al. ff19SB: Amino-acid-specific protein backbone parameters trained against quantum mechanics energy surfaces in solution. J. Chem. Theory Comput. 16, 528\u2013552 (2020).","DOI":"10.1021\/acs.jctc.9b00591"},{"key":"12859_CR45","doi-asserted-by":"crossref","unstructured":"He, X., Man, V. H., Yang, W. & Lee, T. S.  J. Chem. Phys. 153, 114502 (2020).","DOI":"10.1063\/5.0019056"},{"key":"12859_CR46","doi-asserted-by":"crossref","unstructured":"Holmberg, N., Ryde, U. & No, L. B. Prot. Eng 12, 851\u2013856 (1999).","DOI":"10.1093\/protein\/12.10.851"},{"key":"12859_CR47","unstructured":"Frisch, M. J. et al. Preprint.  (Gaussian, Inc., 2016)."},{"key":"12859_CR48","doi-asserted-by":"publisher","unstructured":"O\u2019Boyle, N. M., Banck, M., James, C. A., Morley, C. & Vandermeersch, T. and G. R. H. Open babel: An open chemical toolbox. J. Cheminf. 3. Preprint  (2011). https:\/\/doi.org\/10.1186\/1758-2946-3-33","DOI":"10.1186\/1758-2946-3-33"},{"key":"12859_CR49","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1016\/0021-9991(77)90098-5","volume":"23","author":"JP Ryckaert","year":"1977","unstructured":"Ryckaert, J. P., Ciccotti, G. & Berendsen, H. J. C. Numerical integration of the cartesian equations of motion of a system with constraints: molecular dynamics of n-alkanes. J. Comput. Phys. 23, 327\u2013341 (1977).","journal-title":"J. Comput. Phys."},{"key":"12859_CR50","doi-asserted-by":"publisher","first-page":"170","DOI":"10.1021\/acs.jcim.6b00373","volume":"57","author":"IY Ben-Shalom","year":"2017","unstructured":"Ben-Shalom, I. Y., Pfeiffer-Marek, S., Baringhaus, K. H. & Gohlke, H. Efficient approximation of ligand rotational and translational entropy changes upon binding for use in MM-PBSA calculations. J. Chem. Inf. Model. 57, 170\u2013189 (2017).","journal-title":"J. Chem. Inf. Model."},{"key":"12859_CR51","doi-asserted-by":"publisher","first-page":"3768","DOI":"10.1021\/ct200163c","volume":"7","author":"S Genheden","year":"2011","unstructured":"Genheden, S. & Ryde, U. Comparison of the efficiency of the LIE and MM\/GBSA methods to calculate Ligand-Binding energies. J. Chem. Theory Comput. 7, 3768\u20133778 (2011).","journal-title":"J. Chem. Theory Comput."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-12859-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-12859-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-12859-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,8]],"date-time":"2025-09-08T10:52:21Z","timestamp":1757328741000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-12859-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8,1]]},"references-count":51,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["12859"],"URL":"https:\/\/doi.org\/10.1038\/s41598-025-12859-x","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,8,1]]},"assertion":[{"value":"30 April 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 July 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 August 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"28111"}}